Effect of an antibiotic algorithm on the adequacy of empiric antibiotic therapy given by a medical emergency team

Journal of Critical Care

Volumn 27, Issue 1, 2012, Pages 45-50

  Miano, Todd A ^a   Powell, Elizabeth ^b   Schweickert, William D ^b   Morgan, Steven ^a   Binkley, Shawn ^a   Sarani, Babak ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CASPOFUNGIN; CEFEPIME; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANAEROBIC BACTERIUM; ANTIBIOTIC ALGORITHM; ANTIBIOTIC DE ESCALATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG DOSE ESCALATION; DRUG TREATMENT FAILURE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS PARAINFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RAPID RESPONSE TEAM; RETROSPECTIVE STUDY; SALMONELLA TYPHI; SEPTIC SHOCK; STREPTOCOCCUS; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AGED; ALGORITHMS; ANTI-BACTERIAL AGENTS; DECISION SUPPORT SYSTEMS, CLINICAL; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84856438807     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.05.023     Document Type: Article

References (16)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
3. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
4. Ferrer R., Artigas A., Levy M.M., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
5. Levy M.M., Dellinger R.P., Townsend S.R., et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010, 38:367-374.
6. Sebat F., Musthafa A.A., Johnson D., et al. Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years. Crit Care Med 2007, 35:2568-2575.
7. Sarani B., Brenner S.R., Gabel B., et al. Improving sepsis care through systems change: the impact of a medical emergency team. Jt Comm J Qual Patient Saf 2008, 34:179-182. 25.
8. Carmeli Y., Troillet N., Karchmer A.W., et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999, 159:1127-1132.
9. Tumbarello M., Spanu T., Sanguinetti M., et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006, 50:498-504.
10. Weinstein M.P., Towns M.L., Quartey S.M., et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997, 24:584-602.
11. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
12. Vogelaers D., De Bels D., Foret F., et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates-a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents 2010, 35:375-381.
13. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873.
14. American Thoracic Society; Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
15. Beardsley J.R., Williamson J.C., Johnson J.W., et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006, 130:787-793.
16. Lancaster J.W., Lawrence K.R., Fong J.J., et al. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes. Pharmacotherapy 2008, 28:852-862.